Sign up to save your podcasts
Or
Share Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org.
Show reference:
https://www.neurology.org/doi/10.1212/WNL.0000000000209745
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org.
Show reference:
https://www.neurology.org/doi/10.1212/WNL.0000000000209745
More shows like Neurology Minute
View all
JAMA Clinical Reviews
496 Listeners
Neurology® Podcast
300 Listeners
Practical Neurology Podcast
50 Listeners
Mayo Clinic Talks
290 Listeners
The Curbsiders Internal Medicine Podcast
3,333 Listeners
Emergency Medical Minute
263 Listeners
JAMA Neurology Author Interviews
13 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
Short Wave
6,411 Listeners
Neurology Exam Prep Podcast
179 Listeners
The Curious Clinicians
369 Listeners
Continuum Audio
79 Listeners